BB Biotech

Switzerland
Staffelbach, Aargau, Switzerland, 8200

Company profile

BB Biotech company profile

BB Biotech is an equity fund launched and managed by Bellevue Asset Management. It invests in the public equity markets across the globe. BB Biotech primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. It employs a fundamental analysis to create its portfolio. BB Biotech began operation on November 09, 1993. It has its headquarters in Schaffhausen in Switzerland.

Business identity

Contact email
[email protected]
Phone number
+41526240845
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
1993-11-09

Headquarters

Postal code
8200
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$224,910
Last funding
Post IPO Equity / $224,910 / 2022-11-03
Last equity funding
Post IPO Equity / $224,910
Articles
13
Exited on
1997-12-10

Founders and investors

No public relation records are available.